Results 141 to 150 of about 2,003 (162)

Genomic Context and Mechanisms of the ACVR1 Mutation in Fibrodysplasia Ossificans Progressiva

Biomedicines, 2021
Renata Bocciardi, Ravazzolo Roberto, Bocciardi Renata   +2 more
exaly  

Neofunction of ACVR1 in fibrodysplasia ossificans progressiva

Proceedings of the National Academy of Sciences of the United States of America, 2015
Junya Toguchida, Makoto Ikeya, Shuichi Matsuda   +2 more
exaly  

Fibrodysplasia ossificans progressiva and hearing loss

International Journal of Pediatric Otorhinolaryngology, 1987
Mads Sølvsten Sørensen, M S Sørensen
exaly  

Druggable targets, clinical trial design and proposed pharmacological management in fibrodysplasia ossificans progressiva

Expert Opinion on Orphan Drugs, 2020
Robert Pignolo, Frederick Kaplan
exaly  

Quality of life of patients with fibrodysplasia ossificans progressiva

Journal of Children's Orthopaedics, 2015
Douglas Colmenares-Bonilla
exaly  

Fibrodysplasia Ossificans Progressiva

2016
openaire   +2 more sources

Scalp nodules as a presenting sign of fibrodysplasia ossificans progressiva: A register-based study

Journal of the American Academy of Dermatology, 2011
Christine Bodemer, Sylvie Fraitag, Maryam Piram   +2 more
exaly  

From mysteries to medicines: drug development for fibrodysplasia ossificans progressiva

Expert Opinion on Orphan Drugs, 2013
Robert Pignolo, Frederick Kaplan, Eileen Shore   +2 more
exaly  

Permanent heterotopic ossification at the injection site after diphtheria-tetanus-pertussis immunizations in children who have fibrodysplasia ossificans progressiva

Journal of Pediatrics, 1995
Michael Zasloff, David M Rocke, Frederick Kaplan   +2 more
exaly  

Fibrodysplasia Ossificans Progressiva

2000
Eileen M. Shore, John G. Rogers, Roger Smith, Francis H. Gannon, Martin Delatycki, J. Andoni Urtizberea, James Triffitt, Martine Le Merrer, Frederick S. Kaplan   +8 more
openaire   +1 more source